Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
Background Major depressive disorder (MDD) treatment is characterized by low remission rate and often involves weeks to months of treatment. Identification of pretreatment biomarkers of response may play a critical role in novel drug development, in enhanced prognostic predictions, and perhaps in pr...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-12-01
|
| Series: | Chronic Stress |
| Online Access: | https://doi.org/10.1177/2470547020984726 |